GELESIS INC

Profile

Company Names

GELESIS INC

Addresses

501 BOYLSTON STREET, SUITE 6102, BOSTON, MA 02116

500 BOYLSTON STREET, SUITE 1600, BOSTON, MA 02116

Phone Numbers

617-456-4718
617-482-2333

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$37,693,676.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2015-12-17 
$31,499,980.00 
$33,999,981.00 
$2,500,001.00 
Equity 
2
2011-05-25 
$2,555,000.00 
$2,555,000.00 
$0.00 
Equity 
1
2011-04-30 
$3,638,696.00 
$3,638,696.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
MENDY 
 
AXELRAD 
DIRECTOR
GELESIS INC
ELON 
 
BOMS 
DIRECTOR
GREEN LIFE GUIDES, LLC   |  PAPERG INC   |  PROJECT DECOR, INC.   |  GOLFKICK LLC   |  UBIQUITY GLOBAL SERVICES, INC.   |  RIVALRIES UNLIMITED LLC   |  CORE INFORMATICS, LLC   |  CENTRI TECHNOLOGY, INC.   |  PAPERG, INC   |  GELESIS INC   |  DOMINO MEDIA GROUP, INC.   |  ONEBIOPHARMA INC.   |  LUMICELL, INC.
ERIC 
 
ELENKO 
DIRECTOR
GELESIS INC   |  KARUNA PHARMACEUTICALS INC   |  TAL MEDICAL INC.   |  AKILI INTERACTIVE LABS, INC.   |  SEAPORT THERAPEUTICS, INC.
MEGHAN 
 
FITZGERALD 
DIRECTOR
SENIORLINK INC   |  GELESIS INC   |  TINKERGARTEN, INC.
ROBERT 
 
FORRESTER 
DIRECTOR
MOMELAN TECHNOLOGIES, INC.   |  VERASTEM, INC.   |  GELESIS INC   |  PILLAR BIOSCIENCES INC.
RISHI 
 
GUPTA 
DIRECTOR
GELESIS INC   |  SIENTRA, INC.   |  AVITIDE, INC.   |  SYMBIOMIX THERAPEUTICS, LLC   |  DIMENSION THERAPEUTICS, INC.   |  MEVES PHARMACEUTICALS, INC.   |  ATTENUA, INC.   |  TURNSTONE BIOLOGICS CORP.   |  GOLDEN TEAK CAPITAL L.P.   |  NEUROPACE INC   |  VERONA PHARMA PLC   |  CHARM THERAPEUTICS INC.   |  DELFI DIAGNOSTICS, INC.   |  AER THERAPEUTICS, INC.   |  HELICORE BIOVENTURES I, INC.   |  ENLIVEN THERAPEUTICS, INC.   |  WILSHIRE SELECTIVE OPPORTUNITIES PROGRAM SPC - WILSOP SEGREGATED PORTFOLIO 5
JOHN 
 
LAMATTINA 
DIRECTOR
GELESIS INC   |  LIGAND PHARMACEUTICALS INC   |  IMMUNOME INC.   |  VEDANTA BIOSCIENCES, INC.
ELLIOT 
 
MALTZ 
EXECUTIVE OFFICER
GELESIS INC   |  GELESIS HOLDINGS, INC.   |  ORGENESIS INC.
YISHAI 
 
ZOHAR 
EXECUTIVE OFFICER, DIRECTOR
GELESIS INC   |  GELESIS HOLDINGS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2015-12-30
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2015-12-17 
2011-06-09
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-05-25 
2011-05-12
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-04-30 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#